CLINICAL_TRIALS
trial_result
· 2017-07-07
Clinical Trial Update: Comparing HAI-90Y (SIR-spheres)+Chemotx LV5FU2 Versus Chemotx LV5FU2 Alone to Treat Colorectal Cancer [Phase 3]
Summary
Phase 3 clinical trial update comparing hepatic arterial infusion with Y-90 SIR-spheres plus LV5FU2 versus LV5FU2 alone for colorectal cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Universiteit Antwerpen | Conditions: Colorectal Cancer | Phase 3 | Status: UNKNOWN